Estuardo Aguilar-Cordova, M.D., inf.
2020
In 2020, Estuardo Aguilar-Cordova, M.D., inf. earned a total compensation of $740.2K as Founder and Former Chief Executive Officer and Chief Scientific Officer at Candel Therapeutics.
Compensation breakdown
| Bonus | $104,000 |
|---|---|
| Non-Equity Incentive Plan | $191,250 |
| Salary | $444,903 |
| Total | $740,153 |
inf received $444.9K in salary, accounting for 60% of the total pay in 2020.
inf also received $104K in bonus and $191.3K in non-equity incentive plan.
Rankings
In 2020, Estuardo Aguilar-Cordova, M.D., inf.'s compensation ranked 9,783rd out of 13,090 executives tracked by ExecPay. In other words, inf earned more than 25.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,783 out of 13,090 | 25th |
Division Manufacturing | 4,204 out of 5,621 | 25th |
Major group Chemicals And Allied Products | 1,724 out of 2,254 | 24th |
Industry group Drugs | 1,511 out of 1,954 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 345 out of 411 | 16th |
Source: SEC filing on September 2, 2022.
inf's colleagues
We found two more compensation records of executives who worked with Estuardo Aguilar-Cordova, M.D., inf. at Candel Therapeutics in 2020.